From: Preserving brain function in a comatose patient with septic hyperpyrexia (41.6 °C): a case report
Day | WBC count (Range) | Temperature maximum | Antibiotic regimen based on culture and sensitivity studies | Microorganism |
---|---|---|---|---|
1–7 | 11.9–18.6 | 37.1 °C (98.7 °F) | Piperacillin-tazobactam 3.375 g intravenously Q 8 hours. Vancomycin 1 g intravenously Q 12 hours | K. pneumoniae – sputum |
8–13 | 10.6–29.5 | 41.6 °C (106.9 °F) | Levofloxacin 500 mg intravenously Q 48 hours. Micafungin 100 mg intravenously Q daily | K. pneumoniae – sputum. C. albicans – blood |
14–22 | 9.1–22.1 | 38.9 °C (102 °F) | Levofloxacin 500 mg intravenously Q 48 hours | C. albicans – blood and sputum |
23–30 | 12.1–20.9 | 39.7 °C (103.4 °F) | Fluconazole 100 mg/50 ml, 100 mg Q 24 hours | C. albicans – blood |
31–41 | 13.9–29.7 | 36.7–39.4 °C (98–103 °F) | Levofloxacin 500 mg intravenously Q 48 hours. Piperacillin-tazobactam 3.375 g intravenously Q 8 hours | P. aeruginosa – stool and wound |
42–49 | 12.6–17.5 | 36.7–39.4 °C (98–103 °F) | Daptomycin 500 mg intravenously Q 8 hours | S. epidermidis – skin, stool, blood |
50–57 | 7.2–17.5 | 36.8–39.4 °C (98.3–102.9 °F) | Metronidazole 500 mg intravenously Q 8 hours. Linezolid 600 mg/300 ml Q 12 hours | MRSA – sputum. C. difficile – stool |
58–67 | 10.1–15.9 | 36.5–37.6 °C (97.7–99.7 °F) | Levofloxacin 750 mg intravenously Q 24 hours. Daptomycin 500 mg intravenously Q 8 hours | MRSA – sputum |
68–78 | 7.3–18.2 | 36.5–39.0 °C (97.7–102.2 °F) | Vancomycin 1 g intravenously Q 12 hours. Imipenem 500 mg intravenously Q 8 hours | MRSA – Blood |